SOURCE: Cypress Bioscience Inc.

Cypress Bioscience Inc.

February 26, 2010 06:30 ET

Cypress Bioscience, Inc. to Participate in RBC Capital Markets Healthcare Conference

SAN DIEGO, CA--(Marketwire - February 26, 2010) -  Cypress Bioscience, Inc. (NASDAQ: CYPB) today announced that Sabrina Martucci Johnson, its Chief Operating Officer and Chief Financial Officer, will participate in the RBC Capital Markets Healthcare Conference on March 2, 2010.
The RBC conference is being held at the New York Palace Hotel in New York, NY. Ms. Johnson is scheduled to participate in a panel discussion titled 'New Developments in Neurology' on Tuesday, March 2nd at 9:00 a.m. Eastern Time. The audio broadcast of this presentation can be accessed at
http://www.wsw.com/webcast/rbc116/panel3.

A replay of the presentation will be available at the same web address as well as on Cypress' website, http://www.cypressbio.com/events.php.

About Cypress Bioscience
Cypress Bioscience, Inc. provides therapeutics and personalized medicine services, facilitating improved and individualized patient care. Cypress addresses the evolving needs of specialist physicians and their patients by identifying unmet medical needs in the areas of pain, rheumatology, and physical medicine and rehabilitation, including challenging disorders such as fibromyalgia and rheumatoid arthritis. This approach to improving patient care creates a unique partnership with physicians. Current products include Savella® (milnacipran HCI) and the Avise PGSM and Avise MCVSM therapeutic monitoring, diagnostic and prognostic tests for rheumatoid arthritis.

For more information about Cypress, please visit the Company's website at www.cypressbio.com.

Contact Information

  • For additional information please contact

    Mary Gieson
    Investor Relations Manager
    (858) 452-2323
    Email Contact